Skip to main content
. 2009 Oct 12;8:41. doi: 10.1186/1476-511X-8-41

Figure 2.

Figure 2

Ezetimibe improved apolipoprotein B (apoB) to apolipoprotein A-I (apoA-I) ratio in patients with hypercholesterolemia. Ezetimibe improved apoB to apoA-I ratio in patients with hypercholesterolemia. apoB and apoA were measured before and after 22-week ezetimibe administration in patients with atherosclerosis-prone hypercholesterolemia (n = 14). Bars represent the mean value of the ratio ± SD.